+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Intracranial Spring Coil Embolization System Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118037
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Intracranial Spring Coil Embolization System Market is projected to reach USD 1.01 Billion in 2026. It is expected to continue growing at a CAGR of 10.40%, reaching USD 1.85 Billion by 2032.

Intracranial Spring Coil Embolization Systems: Executive Overview

Intracranial spring coil embolization systems are endovascular devices used to treat selected intracranial aneurysms by promoting clot formation within the aneurysm sac and reducing blood flow. Their adoption is shaped by clinical evidence, operator expertise, hospital neurointerventional capacity, device deliverability, imaging support, reimbursement, and the balance between endovascular treatment and alternatives such as surgical clipping or flow diversion. The market is clinically sensitive: product selection depends on aneurysm anatomy, rupture status, access characteristics, coil stability, adjunctive technologies, and institutional protocols.

Clinical Workflow, Device Design, and Evidence Are Reshaping Adoption

The landscape is shifting toward more precise treatment planning, improved catheter navigation, and coil systems designed to support controlled deployment, stable packing, and procedural efficiency. Wider use of advanced neuroimaging and multidisciplinary cerebrovascular teams is strengthening patient selection and follow-up. At the same time, clinicians are evaluating coils alongside balloon-assisted coiling, stent-assisted coiling, flow-diversion approaches, and microsurgical options, making comparative evidence and post-procedure durability increasingly important.

Regulatory scrutiny, training requirements, supply continuity, and hospital purchasing discipline also influence adoption. The strongest opportunities are associated with systems that integrate reliably into established workflows while offering clear procedural value without compromising safety.

Artificial Intelligence Is Improving Detection, Planning, and Follow-Up

Artificial intelligence is contributing to the broader cerebrovascular care pathway through image triage, aneurysm detection, segmentation, measurement, rupture-risk assessment, and procedural planning. These tools may help prioritize suspected subarachnoid hemorrhage, standardize anatomical characterization, and support selection of treatment strategies, but they do not replace specialist judgment or validated clinical evidence.

During and after treatment, AI-enabled image analysis may assist with device-position assessment, residual filling surveillance, and longitudinal comparison. Effective deployment requires high-quality imaging data, transparent validation, cybersecurity controls, integration with clinical systems, and clear accountability for decisions. For device developers and providers, the practical value lies in workflow augmentation rather than unsupported automation claims.

Regional Insights: Access and Neurointerventional Capacity Remain Uneven

North America combines advanced neurointerventional infrastructure, specialized operators, and comparatively mature evidence-based procurement, while reimbursement rules and hospital value assessments influence product uptake. Europe benefits from sophisticated cerebrovascular centers, although access, procurement, and regulatory implementation vary across countries. Asia-Pacific presents strong clinical capability in leading urban centers alongside meaningful differences in specialist availability, training, and access between metropolitan and rural settings.

Latin America is characterized by expanding access in referral hospitals but continuing disparities in emergency pathways, device affordability, and specialist coverage. The Middle East is developing tertiary-care capacity, with adoption concentrated in well-equipped centers and shaped by national health strategies. Africa remains heterogeneous: selected urban institutions provide advanced neurointerventional services, while limited imaging, referral delays, workforce constraints, and procurement barriers restrict broader availability.

Group Insights: Economic and Security Alliances Shape Health-System Priorities

ASEAN markets show varied levels of neurointerventional readiness, with regional centers progressing faster than systems facing workforce and affordability constraints. BRICS countries span substantial differences in domestic manufacturing, specialist capacity, public procurement, and access to advanced imaging. The European Union supports cross-border scientific collaboration and broad clinical standards, while national reimbursement and procurement decisions remain important.

G7 systems generally have established specialist networks, rigorous evidence expectations, and structured regulatory or reimbursement processes. GCC countries are investing in advanced tertiary care and specialist infrastructure, creating opportunities where clinical training and referral coordination keep pace. NATO members are not a uniform healthcare market, but many benefit from resilient medical infrastructure, emergency preparedness capabilities, and established referral systems; adoption still depends on civilian health policy and national procurement frameworks.

Country Insights: Capabilities Differ Across Major Treatment Centers

Australia and Canada have concentrated specialist services and large geographic access challenges, making referral networks and telehealth-supported triage important. Brazil and Mexico show strong capability in leading urban hospitals but face regional variation in funding, specialist availability, and access to complex neurointervention. China and India combine advanced centers with substantial internal differences in healthcare access, training, and public-sector procurement.

France, Germany, Italy, Spain, and the United Kingdom maintain established neurovascular services, with adoption influenced by clinical guidelines, hospital purchasing, reimbursement structures, and evidence requirements. Japan and South Korea have sophisticated imaging and specialist capabilities, while aging populations and procedural standardization remain relevant considerations. Russia’s access landscape is shaped by regional disparities, healthcare infrastructure, procurement conditions, and availability of specialized expertise. In the United States, high procedural specialization and extensive referral networks coexist with payer, evidence, and hospital-value pressures.

Action Priorities for Leaders: Build Evidence, Access, and Workflow Fit

Industry leaders should prioritize robust clinical evidence that compares procedural performance, safety, retreatment considerations, and patient-selection criteria across relevant aneurysm anatomies. Product development should focus on predictable deployment, catheter compatibility, visibility, retrieval control, and straightforward integration with adjunctive techniques. Training programs, simulation, proctoring, and case-support resources can help expand safe use without weakening quality standards.

Commercial and operational planning should be tailored to regional referral patterns, reimbursement realities, procurement requirements, and infrastructure constraints. Leaders should also develop transparent AI governance, protect patient data, validate algorithms across diverse populations, and measure real-world outcomes. Supply resilience, post-market surveillance, and partnerships with hospitals and professional societies can reinforce trust and improve continuity of care.

Research Methodology: Evidence-Led Assessment of Clinical and System Factors

This executive summary is structured around the clinical role of intracranial spring coil embolization systems and the factors that influence their adoption. The assessment framework considers device function, aneurysm-treatment pathways, competing interventions, imaging and procedural workflow, regulatory and reimbursement conditions, hospital infrastructure, specialist training, and geographic access.

Regional, group, and country comparisons are qualitative and focus on documented differences in healthcare capacity, referral organization, procurement, clinical specialization, and technology readiness. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should be supplemented with current regulatory documents, peer-reviewed clinical evidence, national guidelines, reimbursement policies, and institution-level outcomes before strategic or clinical decisions are made.

Conclusion: Durable Progress Depends on Precision, Evidence, and Equitable Access

Intracranial spring coil embolization systems remain part of a technically demanding treatment ecosystem in which outcomes depend on appropriate patient selection, skilled operators, reliable devices, and coordinated follow-up. Innovation is moving beyond the coil itself toward integrated imaging, planning, workflow support, data analysis, and quality monitoring.

The most durable progress will come from aligning device performance with validated clinical benefit, strengthening neurointerventional capacity, and addressing disparities in referral, training, affordability, and emergency care. Organizations that combine evidence-led product development with responsible digital integration and region-specific implementation are best positioned to support safer and more consistent aneurysm treatment.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Intracranial Spring Coil Embolization System Market, by Technology
7.1. Introduction
7.2. Bare Platinum Coil
7.2.1. Electrolytic Detachable Coil
7.2.2. Mechanical Detachable Coil
7.3. Bioactive Coated Coil
7.3.1. Polyglycolic Acid Coated Coil
7.3.2. Polyglycolic-Lactic Acid Coated Coil
7.4. Hydrogel Coated Coil
7.4.1. Expanding Hydrogel Coil
7.4.2. Prehydrated Hydrogel Coil
8. Intracranial Spring Coil Embolization System Market, by Sales Channel
8.1. Introduction
8.2. Direct Tender
8.3. Distributor
9. Intracranial Spring Coil Embolization System Market, by Price Tier
9.1. Introduction
9.2. Economy Price
9.3. Premium Price
9.4. Standard Price
10. Intracranial Spring Coil Embolization System Market, by Application
10.1. Introduction
10.2. Arteriovenous Malformation
10.2.1. Brain Avm
10.2.2. Spinal Avm
10.3. Intracranial Aneurysm
10.3.1. Dissecting Aneurysm
10.3.2. Fusiform Aneurysm
10.3.3. Saccular Aneurysm
10.4. Tumor Embolization
10.4.1. Glioma Embolization
10.4.2. Meningioma Embolization
11. Intracranial Spring Coil Embolization System Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.3. Hospital
11.4. Specialty Clinic
12. Intracranial Spring Coil Embolization System Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Intracranial Spring Coil Embolization System Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Intracranial Spring Coil Embolization System Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Acandis GmbH & Co. KG
16.2. Asahi Intecc Co., Ltd.
16.3. C.R. Bard, Inc.
16.4. Cook Group Incorporated
16.5. Integer Holdings Corporation
16.6. Johnson & Johnson
16.7. Kaneka Corporation
16.8. Lepu Medical Technology Co., Ltd.
16.9. Medtronic plc
16.10. Merit Medical Systems, Inc.
16.11. Micro Therapeutics, Inc.
16.12. MicroPort Scientific Corporation
16.13. Minnetronix Medical, Inc.
16.14. Nico Corporation
16.15. Penumbra, Inc.
16.16. phenox GmbH
16.17. Rapid Medical Ltd.
16.18. Stryker Corporation
16.19. SurModics, Inc.
16.20. Terumo Corporation
16.21. W. L. Gore & Associates, Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Intracranial Spring Coil Embolization System Market, Years Considered for the Study
FIGURE 2. Global Intracranial Spring Coil Embolization System Market, Research Design
FIGURE 3. Global Intracranial Spring Coil Embolization System Market, Research Framework
FIGURE 4. Global Intracranial Spring Coil Embolization System Market, Data Triangulation
FIGURE 5. Global Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Intracranial Spring Coil Embolization System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Intracranial Spring Coil Embolization System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 9. Global Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2025 vs 2032 (%)
FIGURE 11. Global Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Intracranial Spring Coil Embolization System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Intracranial Spring Coil Embolization System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Intracranial Spring Coil Embolization System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Intracranial Spring Coil Embolization System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Intracranial Spring Coil Embolization System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Intracranial Spring Coil Embolization System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Intracranial Spring Coil Embolization System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Intracranial Spring Coil Embolization System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Intracranial Spring Coil Embolization System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Intracranial Spring Coil Embolization System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Intracranial Spring Coil Embolization System Market Segmentation & Coverage
TABLE 2. Global Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Bare Platinum Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bare Platinum Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bare Platinum Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Electrolytic Detachable Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Electrolytic Detachable Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Electrolytic Detachable Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Mechanical Detachable Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Mechanical Detachable Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Mechanical Detachable Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Bioactive Coated Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Bioactive Coated Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Bioactive Coated Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Polyglycolic Acid Coated Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Polyglycolic Acid Coated Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Polyglycolic Acid Coated Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Polyglycolic-Lactic Acid Coated Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Polyglycolic-Lactic Acid Coated Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Polyglycolic-Lactic Acid Coated Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Hydrogel Coated Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Hydrogel Coated Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Hydrogel Coated Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Expanding Hydrogel Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Expanding Hydrogel Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Expanding Hydrogel Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Prehydrated Hydrogel Coil Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Prehydrated Hydrogel Coil Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Prehydrated Hydrogel Coil Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 32. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 39. Global Economy Price Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Economy Price Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Economy Price Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Premium Price Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Premium Price Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Premium Price Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Standard Price Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Standard Price Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Standard Price Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 49. Global Arteriovenous Malformation Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Arteriovenous Malformation Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Arteriovenous Malformation Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Brain Avm Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Brain Avm Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Brain Avm Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Spinal Avm Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Spinal Avm Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Spinal Avm Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Intracranial Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Intracranial Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Intracranial Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Dissecting Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Dissecting Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Dissecting Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Fusiform Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Fusiform Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Fusiform Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Saccular Aneurysm Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Saccular Aneurysm Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Saccular Aneurysm Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Tumor Embolization Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Tumor Embolization Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Tumor Embolization Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Glioma Embolization Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Glioma Embolization Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Glioma Embolization Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Meningioma Embolization Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Meningioma Embolization Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Meningioma Embolization Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. North America Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. North America Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. North America Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 105. North America Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 106. North America Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 107. North America Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 108. North America Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 109. North America Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. North America Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 111. North America Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 112. North America Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 113. North America Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Latin America Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Latin America Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. Latin America Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 117. Latin America Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 118. Latin America Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 119. Latin America Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 120. Latin America Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 121. Latin America Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Latin America Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 123. Latin America Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 124. Latin America Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 125. Latin America Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Europe Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Europe Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. Europe Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 129. Europe Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 130. Europe Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 131. Europe Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 132. Europe Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 133. Europe Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Europe Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 135. Europe Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 136. Europe Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 137. Europe Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Middle East Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Middle East Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 140. Middle East Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 141. Middle East Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 142. Middle East Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 143. Middle East Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 144. Middle East Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 145. Middle East Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Middle East Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 147. Middle East Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 148. Middle East Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 149. Middle East Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Africa Intracranial Spring Coil Embolization System Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Africa Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. Africa Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 153. Africa Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 154. Africa Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 155. Africa Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 156. Africa Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 157. Africa Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 158. Africa Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 159. Africa Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 160. Africa Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 161. Africa Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Global Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. ASEAN Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. ASEAN Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 166. ASEAN Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 167. ASEAN Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 168. ASEAN Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 169. ASEAN Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 170. ASEAN Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. ASEAN Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 172. ASEAN Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 173. ASEAN Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 174. ASEAN Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. GCC Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. GCC Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. GCC Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 178. GCC Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 179. GCC Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 180. GCC Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 181. GCC Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 182. GCC Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. GCC Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 184. GCC Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 185. GCC Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 186. GCC Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. European Union Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. European Union Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. European Union Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 190. European Union Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 191. European Union Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 192. European Union Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 193. European Union Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 194. European Union Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. European Union Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 196. European Union Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 197. European Union Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 198. European Union Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. BRICS Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. BRICS Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. BRICS Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 202. BRICS Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 203. BRICS Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 204. BRICS Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 205. BRICS Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 206. BRICS Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. BRICS Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 208. BRICS Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 209. BRICS Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 210. BRICS Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. G7 Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. G7 Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. G7 Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 214. G7 Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 215. G7 Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 216. G7 Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 217. G7 Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 218. G7 Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. G7 Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 220. G7 Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 221. G7 Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 222. G7 Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. NATO Intracranial Spring Coil Embolization System Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. NATO Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. NATO Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 226. NATO Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 227. NATO Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 228. NATO Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 229. NATO Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 230. NATO Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. NATO Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 232. NATO Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 233. NATO Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 234. NATO Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Global Intracranial Spring Coil Embolization System Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. United States Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 237. United States Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. United States Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 239. United States Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 240. United States Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 241. United States Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 242. United States Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 243. United States Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. United States Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 245. United States Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 246. United States Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 247. United States Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Canada Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 249. Canada Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 250. Canada Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 251. Canada Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 252. Canada Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 253. Canada Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 254. Canada Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 255. Canada Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. Canada Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 257. Canada Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 258. Canada Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 259. Canada Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Mexico Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 261. Mexico Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. Mexico Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 263. Mexico Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 264. Mexico Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 265. Mexico Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 266. Mexico Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 267. Mexico Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Mexico Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 269. Mexico Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 270. Mexico Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 271. Mexico Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Brazil Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 273. Brazil Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 274. Brazil Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 275. Brazil Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 276. Brazil Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 277. Brazil Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 278. Brazil Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 279. Brazil Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Brazil Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 281. Brazil Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 282. Brazil Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 283. Brazil Intracranial Spring Coil Embolization System Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. United Kingdom Intracranial Spring Coil Embolization System Market Size, 2017-2032 (USD Million)
TABLE 285. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 286. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Bare Platinum Coil, 2017-2032 (USD Million)
TABLE 287. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Bioactive Coated Coil, 2017-2032 (USD Million)
TABLE 288. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Hydrogel Coated Coil, 2017-2032 (USD Million)
TABLE 289. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 290. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Price Tier, 2017-2032 (USD Million)
TABLE 291. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Arteriovenous Malformation, 2017-2032 (USD Million)
TABLE 293. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Intracranial Aneurysm, 2017-2032 (USD Million)
TABLE 294. United Kingdom Intracranial Spring Coil Embolization System Market Size, by Tumor Embolization, 2017-2032 (USD Million)
TABLE 295

Companies Mentioned

  • Acandis GmbH & Co. KG
  • Asahi Intecc Co., Ltd.
  • C.R. Bard, Inc.
  • Cook Group Incorporated
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Kaneka Corporation
  • Lepu Medical Technology Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro Therapeutics, Inc.
  • MicroPort Scientific Corporation
  • Minnetronix Medical, Inc.
  • Nico Corporation
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • SurModics, Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.